Advertisement

Topics

Pharmacopeia Drug Discovery Company Profile

15:46 EDT 21st September 2018 | BioPortfolio

Pharmacopeia is committed to discovering and developing novel therapeutics to address significant medical needs. The Company has a broad portfolio advancing toward clinical validation, both independently and with partners. Pharmacopeia's most advanced internal program is a dual-acting angiotensin and endothelin receptor antagonist (DARA) for hypertension and diabetic kidney disease for which Phase 1 clinical trials are underway. Other internal proprietary programs address primarily immunoregulation. Pharmacopeia's collaborative efforts have resulted in a portfolio that includes one partnered program currently in Phase 2 clinical trials targeting chronic obstructive pulmonary disease (COPD) and four partnered programs in Phase 1 clinical trials targeting rheumatoid arthritis, oncology, metabolic and inflammatory diseases. Four additional partnered compounds are in preclinical development. Pharmacopeia's current strategic partnerships are with Cephalon, GlaxoSmithKline, Organon and Wyeth.

Location

3000 Eastpark Blvd.
Cranbury
New Jersey
08512
United States of America

Contact

Phone: 609-452-3600
Fax: 609-452-3672
Email: webmaster@pharmacop.com


News Articles [1383 Associated News Articles listed on BioPortfolio]

The Current issue of “The view from here” is concerned with nanoscience in drug discovery.

The topic of this month’s newsletter from Drug Discovery Today is “nanoscience in drug discovery”

The Current issue of “The view from here” is concerned with Allosterism in Drug Discovery.

The topic of this month’s newsletter from Drug Discovery Today is “Allosterism in Drug Discovery”.

Pharmacophore modeling and applications in drug discovery: challenges and recent advances

The most downloaded article from Drug Discovery Today in Q2 2010 was by Sheng-Yong Yang and deals with the application of pharmacophore modeling to drug discovery.

Researchers use AI to learn 'language' of drug discovery

Researchers from Israel are the latest to show that AI and deep learning could make the drug discovery process more efficient, by getting a computer to learn the “vocabulary” of drug discovery. I...

The Rise of Multiplex Immunoassays in Drug Discovery

ArticleThese sensitive assays are used in both the preclinical and clinical stages of drug development, where they can evaluate drug response biomarkers, immunotherapy success, and toxicity.

High-Throughput Flow Cytometry in Drug Discovery

NewsA new special issue of SLAS Discovery reflects examples of the recent groundswell of creative new applications for high-throughput flow cytometry (HTFC) in drug discovery.

Drug Discovery and Life Science Magazine

Written and edited for the multidisciplinary market of drug discovery and life science research, Modern Drug Discovery contains information that is

Innovate UK funds AI drug discovery platform

Innovate UK has been awarded a grant to support the development of an artificial intelligence (AI) drug discovery project by...Read More... The post Innovate UK funds AI drug discovery platform appear...

PubMed Articles [3069 Associated PubMed Articles listed on BioPortfolio]

Renovation as innovation: is repurposing the future of drug discovery research?

Challenges with biomarkers in cancer drug discovery and development.

The A-Z of Zika drug discovery.

Despite the recent outbreak of Zika virus (ZIKV), there are still no approved treatments, and early-stage compounds are probably many years away from approval. A comprehensive A-Z review of the recent...

Translational in vitro research: integrating 3D drug discovery and development processes into the drug development pipeline.

As we witness steady progress towards the development of robust, scalable, and reproducible 3D tissue models for preclinical drug testing, there is a need for systematic physiological and pharmacologi...

Translation of innovative chemistry into screening libraries: an exemplar partnership from the European Lead Factory.

The identification of high-quality starting points for drug discovery is an enduring challenge in medicinal chemistry. Yet, the chemical space explored in discovery programmes tends be limited by the ...

Clinical Trials [2405 Associated Clinical Trials listed on BioPortfolio]

Discovery Elbow Multi-Center Prospective Study

The purpose of this prospective clinical trial is to document the performance and clinical outcomes of Biomet Discovery Elbow.

A Clinical Investigation of the Discovery™ Elbow System

The purpose of this study is to perform a five-year, multi-center prospective evaluation of the Discovery™ Elbow System for outcome and durability. Relief of pain and restoration of fun...

Endometriosis Biomarker Discovery Study

This is a prospective, Single time point, discovery study intending to identify biomarkers that can differentiate endometriosis from other underlying reasons for pelvic pain. Patients unde...

Protein Biomarker Discovery and Validation in Chronic Obstructive Pulmonary Disease (COPD) And Asthma

The purpose of the study is to better understand the function of asthma and COPD, and response to therapy. There are two Phases to this study broken into two arms. In Phase I, our propose ...

Biologic Basis of Liver Cancer From Chronic Hepatitis B

The focus of the study is to identify viral factors and host immune responses that differentiate HBV-related HCC patients from HBV patients who have not progressed to HCC. To that end, the...

Companies [2392 Associated Companies listed on BioPortfolio]

Pharmacopeia Incorporated

Pharmacopeia, Inc. is a leader in enabling technology and technology-based services that accelerate drug discovery and chemical development. Pharmacopeia's laboratory services segment - Pharmacopeia L...

Pharmacopeia Drug Discovery

Pharmacopeia is committed to discovering and developing novel therapeutics to address significant medical needs. The Company has a broad portfolio advancing toward clinical validation, both independen...

Pharmacopeia

Pharmacopeia is a biopharmaceutical company developing small molecule therapeutics to meet the needs of large patient populations suffering from significant unmet medical needs. With multiple internal...

Molecular Simulations Incorporated

Molecular Simulations Inc., a subsidiary of Pharmacopeia, Inc., is a leading provider of molecular modeling, simulation, and informatics software to the world’s foremost pharmaceutical, biotechnolog...

ZHONGBAO CHEMICALS CORP.,LTD

ZBChem is A member of Zhejiang ZhongBao I/E Corp.,Ltd Since 1963.ZBChem is the biggest China Excipients supplier and also supply many kinds of Cosmetic raw materials, Intermediates and API’s Guaran...

More Information about "Pharmacopeia Drug Discovery" on BioPortfolio

We have published hundreds of Pharmacopeia Drug Discovery news stories on BioPortfolio along with dozens of Pharmacopeia Drug Discovery Clinical Trials and PubMed Articles about Pharmacopeia Drug Discovery for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Pharmacopeia Drug Discovery Companies in our database. You can also find out about relevant Pharmacopeia Drug Discovery Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Diabetes
Diabetes is a lifelong condition that causes a person's blood sugar level to become too high. The two main types of diabetes are: type 1 diabetes type 2 diabetes In the UK, diabetes affects approximately 2.9 million people. There are a...


Corporate Database Quicklinks



Searches Linking to this Company Record